Forcyte Biotechnologies
Discover drugs that control how much cells "squeeze" to treat disease
About
In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.
Founders
- Ivan Pushkarsky
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Forcyte Biotechnologies.
See family office activity